C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2006
10/12/2006	WO2006086586A3 Anti-interferon alpha monoclonal antibodies and methods for use
10/12/2006	WO2006085092A3 Methods and uses of antibodies in the purification of interferon
10/12/2006	WO2006081587A3 Stabilized liquid polypeptide formulations
10/12/2006	WO2006081320A3 Pharmaceutical formulation
10/12/2006	WO2006073443A3 Antagonist anti-cd40 monoclonal antibodies and methods for their use
10/12/2006	WO2006055704A3 Antibodies directed to ten-m proteins and uses thereof
10/12/2006	WO2006033742A3 Engineered antibody fragment that irreversibly binds an antigen
10/12/2006	WO2006020706A3 Tie complex binding proteins
10/12/2006	WO2006020258A3 Novel tetravalent bispecific antibody
10/12/2006	WO2006009694A3 Crystal of egfr extracellular domain and cetuximab fab fragment and uses thereof
10/12/2006	WO2005123774A3 Antibodies to west nile virus polypeptides
10/12/2006	WO2005044792A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
10/12/2006	WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
10/12/2006	WO2003073821A3 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
10/12/2006	US20060230465 K203 gene and protein
10/12/2006	US20060229438 Monoclonal antibody derived peptide inhibitors for mycobacterial dna gyrase
10/12/2006	US20060229437 Process for purifying proteins
10/12/2006	US20060229435 Lymphocyte homing receptors
10/12/2006	US20060229432 synthetic vaccine; HIV; multi-antigenic construct comprising carbohydrate antigens linked with polypeptides
10/12/2006	US20060229272 or biological fragments in a colon test sample and comparing to that from a normal colon sample, wherein an increased expression level is indicative of gastrointestinal disorders or a predisposition to gastrointestinal disorders
10/12/2006	US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
10/12/2006	US20060228773 Method for preparing recombinant heterocarpine
10/12/2006	US20060228763 Periostin-based diagnostic assays
10/12/2006	US20060228761 Novel RIP3 associated cell cycle proteins, compositions and methods of use
10/12/2006	US20060228757 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity
10/12/2006	US20060228753 Methods of detecting a phenotype of a polymorphic protein
10/12/2006	US20060228745 Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy
10/12/2006	US20060228715 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
10/12/2006	US20060228712 Incubating the polynucleotide array with at least one of a labeled polynucleotide derived from a coryneform bacterium, a labeled polynucleotide derived from a mutant of the coryneform bacterium or a labeled polynucleotide,detecting any hybridization, analyzing
10/12/2006	US20060228710 Novel therapeutic targets in cancer
10/12/2006	US20060228709 Novel fibulin-like polypeptides
10/12/2006	US20060228706 Methods of diagnosing and treating diabetes and insulin resistance
10/12/2006	US20060228705 Cancer-linked gene as target for chemotherapy
10/12/2006	US20060228378 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses
10/12/2006	US20060228371 Immunological control of beta-amyloid levels in vivo
10/12/2006	US20060228370 7a5/Prognostin and use thereof for the diagnostic and therapy of tumors
10/12/2006	US20060228366 Tumor specific monoclonal antibodies
10/12/2006	US20060228365 Protein and gene involved in myocyte differentiation
10/12/2006	US20060228363 Monoclonal antibody therapy for pancreas cancer
10/12/2006	US20060228361 Dicer interacting proteins and uses therefor
10/12/2006	US20060228360 Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12
10/12/2006	US20060228359 antibody; host cell; hybridoma;
10/12/2006	US20060228358 Antibody molecules having specificity for human il-1 beta
10/12/2006	US20060228357 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
10/12/2006	US20060228356 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease
10/12/2006	US20060228355 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor
10/12/2006	US20060228353 PTH1R and PTH3R receptors, methods and uses thereof
10/12/2006	US20060228351 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor
10/12/2006	US20060228350 Framework-shuffling of antibodies
10/12/2006	US20060228349 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases
10/12/2006	US20060228335 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof
10/12/2006	US20060228332 Assembly and folding of Fc-interferon-beta fusion proteins
10/12/2006	CA2604032A1 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
10/12/2006	CA2603805A1 Use of rip in treating staphylococcus aureus infections
10/12/2006	CA2603480A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/12/2006	CA2603408A1 Process for production of polypeptide by regulation of assembly
10/12/2006	CA2602090A1 Bioactive stents for type ii diabetics and methods for use thereof
10/11/2006	EP1710582A2 Suppressor genes
10/11/2006	EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin
10/11/2006	EP1710311A2 Antigenic polypeptides
10/11/2006	EP1710310A1 Novel serum type streptococcus mutans and utilization of the same
10/11/2006	EP1710308A1 Method of reinforcing antibody activity
10/11/2006	EP1710305A1 Fraction and antibody comprising guinea pig immunoglobulin e
10/11/2006	EP1710256A1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1710255A1 Modified antibodies recognising receptor trimers or higher multimers
10/11/2006	EP1710254A2 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
10/11/2006	EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006	EP1709972A1 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
10/11/2006	EP1709971A1 Peptide antigens useful for the prophylaxis, treatment and diagnosis of poxvirus infections
10/11/2006	EP1709970A1 Human antibodies against EGFR, derived from immunized xenomice
10/11/2006	EP1709448A1 Improved method for diagnosing acute coronary syndrome
10/11/2006	EP1709421A1 Methods for diagnosis and pronosis of cancers of epithelial origin
10/11/2006	EP1709196A2 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders
10/11/2006	EP1709178A1 Methods and compounds for altering the load of hepatitis virus
10/11/2006	EP1709173A2 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
10/11/2006	EP1709168A1 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters
10/11/2006	EP1709150A2 Use of notch pathway interfering agents for treatment of plasma cell disorders
10/11/2006	EP1709083A1 Adenocarcinoma specific antibody sam-6, and uses thereof
10/11/2006	EP1709082A1 Composition for treating pathology associated with msrv/herv-w
10/11/2006	EP1709081A2 Fusion polypeptides capable of activating receptors
10/11/2006	EP1709080A2 ANTIBODIES TO MAdCAM
10/11/2006	EP1709079A2 Compositions and methods for treating t-cell mediated autoimmune diseases
10/11/2006	EP1709078A2 Compositions and methods for inhibiting squamous cell carcinoma
10/11/2006	EP1709077A1 Process for the manufacture of virus safe immunoglobulin
10/11/2006	EP1709076A2 Method for the humanization of antibodies and humanized antibodies thereby obtained
10/11/2006	EP1709073A2 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/11/2006	EP1709067A2 Lawsonia intracellularis subunit vaccines
10/11/2006	EP1708961A2 Treatment of inflammatory bowel diseases with anti-ip-10 antibodies
10/11/2006	EP1708753A1 Use of goat serum for veterinary treatment
10/11/2006	EP1708752A2 Polymer-bound antibody cancer therapeutic agent
10/11/2006	EP1708751A2 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
10/11/2006	EP1708750A1 Targeting of erb antigens
10/11/2006	EP1708745A1 Antibodies for oncogenic strains of hpv and methods of their use
10/11/2006	EP1708743A1 PASSIVE IMMUNIZATION AGAINST i CLOSTRIDIUM DIFFICILE /i DISEASE
10/11/2006	EP1540348A4 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/11/2006	EP1307561B1 Nucleic acids, with the aid of which plants having an altered metabolite content can be produced
10/11/2006	EP1257573B1 New transcription factor carp-2
10/11/2006	EP1210374B1 Human monoclonal antibodies to prostate specific membrane antigen
10/11/2006	EP1173476B1 Soybean protein nutraceuticals
10/11/2006	EP1147134B1 Novel potassium channels and genes encoding these potassium channels

1 ... 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 ... 1494